Wakunaga Pharmaceutical Announces Research Findings on Anti-Aging Effects of Aged Garlic Extract Component "S1PC"; Paper Published in Global Scientific Journal
NQ Score
46/100
N1 Content Completeness
5
AI Summary (NQ-processed)
Wakunaga Pharmaceutical Co., Ltd., a pioneer in aged garlic extract in the global healthcare market, and the Institute for Research on Productive Aging, have jointly announced research findings on the anti-aging effects of S1PC. Their collaborative study proved that S1PC, a component in aged garlic extract, promotes the binding of LKB1/STRAD/MO25, activates sirtuins, increases NAD⁺ concentration in the hypothalamus, and leads to improvements in aging indicators and muscle strengthening in aged mice. Human clinical trials have also been conducted, providing evidence for a new anti-aging methodology. The results will be published in the international scientific journal 'Cell Metabolism' on May 7, 2026.